Genetic profile of syndromic retinitis pigmentosa in Portugal.
Genotype
Inherited retinal diseases
Ophthalmic genetics
Syndromic retinitis pigmentosa
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
08 Jan 2024
08 Jan 2024
Historique:
received:
04
05
2023
accepted:
28
12
2023
revised:
11
12
2023
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
8
1
2024
Statut:
aheadofprint
Résumé
Retinitis pigmentosa (RP) comprises a genetically and clinically heterogeneous group of inherited retinal degenerations, where 20-30% of patients exhibit extra-ocular manifestations (syndromic RP). Understanding the genetic profile of RP has important implications for disease prognosis and genetic counseling. This study aimed to characterize the genetic profile of syndromic RP in Portugal. Multicenter, retrospective cohort study. Six Portuguese healthcare providers identified patients with a clinical diagnosis of syndromic RP and available genetic testing results. All patients had been previously subjected to a detailed ophthalmologic examination and clinically oriented genetic testing. Genetic variants were classified according to the American College of Medical Genetics and Genomics; only likely pathogenic or pathogenic variants were considered relevant for disease etiology. One hundred and twenty-two patients (53.3% males) from 100 families were included. Usher syndrome was the most frequent diagnosis (62.0%), followed by Bardet-Biedl (19.0%) and Senior-Løken syndromes (7.0%). Deleterious variants were identified in 86/100 families for a diagnostic yield of 86.0% (87.1% for Usher and 94.7% for Bardet-Biedl). A total of 81 genetic variants were identified in 25 different genes, 22 of which are novel. USH2A and MYO7A were responsible for most type II and type I Usher syndrome cases, respectively. BBS1 variants were the cause of Bardet-Biedl syndrome in 52.6% of families. Best-corrected visual acuity (BCVA) records were available at baseline and last visit for 99 patients (198 eyes), with a median follow-up of 62.0 months. The mean BCVA was 56.5 ETDRS letters at baseline (Snellen equivalent ~ 20/80), declining to 44.9 ETDRS letters (Snellen equivalent ~ 20/125) at the last available follow-up (p < 0.001). This is the first multicenter study depicting the genetic profile of syndromic RP in Portugal, thus contributing toward a better understanding of this heterogeneous disease group. Usher and Bardet-Biedl syndromes were found to be the most common types of syndromic RP in this large Portuguese cohort. A high diagnostic yield was obtained, highlighting current genetic testing capabilities in providing a molecular diagnosis to most affected individuals. This has major implications in determining disease-related prognosis and providing targeted genetic counseling for syndromic RP patients in Portugal.
Identifiants
pubmed: 38189974
doi: 10.1007/s00417-023-06360-2
pii: 10.1007/s00417-023-06360-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Solve-Ret
ID : EJPRD19-234
Informations de copyright
© 2024. The Author(s).
Références
Verbakel SK, van Huet RAC, Boon CJF et al (2018) Non-syndromic retinitis pigmentosa. Prog Retin Eye Res 66:157–186. https://doi.org/10.1016/j.preteyeres.2018.03.005
doi: 10.1016/j.preteyeres.2018.03.005
pubmed: 29597005
Ferrari S, Di Iorio E, Barbaro V et al (2011) Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 12:238–249. https://doi.org/10.2174/138920211795860107
doi: 10.2174/138920211795860107
pmcid: 3131731
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet Lond Engl 368:1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7
doi: 10.1016/S0140-6736(06)69740-7
Pierrottet CO, Zuntini M, Digiuni M et al (2014) Syndromic and non-syndromic forms of retinitis pigmentosa: a comprehensive Italian clinical and molecular study reveals new mutations. Genet Mol Res GMR 13:8815–8833. https://doi.org/10.4238/2014.October.27.23
doi: 10.4238/2014.October.27.23
Thompson DA, Ali RR, Banin E et al (2015) Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano symposium. Invest Ophthalmol Vis Sci 56:918–931. https://doi.org/10.1167/iovs.14-16049
doi: 10.1167/iovs.14-16049
pubmed: 25667399
pmcid: 4554258
Maguire AM, Russell S, Wellman JA et al (2019) Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology 126:1273–1285. https://doi.org/10.1016/j.ophtha.2019.06.017
doi: 10.1016/j.ophtha.2019.06.017
pubmed: 31443789
Perea-Romero I, Gordo G, Iancu IF et al (2021) Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications. Sci Rep 11:1526. https://doi.org/10.1038/s41598-021-81093-y
doi: 10.1038/s41598-021-81093-y
pubmed: 33452396
pmcid: 7810997
Bertelsen M, Jensen H, Bregnhøj JF, Rosenberg T (2014) Prevalence of generalized retinal dystrophy in Denmark. Ophthalmic Epidemiol 21:217–223. https://doi.org/10.3109/09286586.2014.929710
doi: 10.3109/09286586.2014.929710
pubmed: 24963760
Pontikos N, Arno G, Jurkute N et al (2020) Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology 127:1384–1394. https://doi.org/10.1016/j.ophtha.2020.04.008
doi: 10.1016/j.ophtha.2020.04.008
Karali M, Testa F, Di Iorio V et al (2022) Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy. Sci Rep 12:20815. https://doi.org/10.1038/s41598-022-24636-1
doi: 10.1038/s41598-022-24636-1
pubmed: 36460718
pmcid: 9718770
Sharon D, Ben-Yosef T, Goldenberg-Cohen N et al (2020) A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Hum Mutat 41:140–149. https://doi.org/10.1002/humu.23903
doi: 10.1002/humu.23903
pubmed: 31456290
Marques JP, Carvalho AL, Henriques J et al (2020) Design, development and deployment of a web-based interoperable registry for inherited retinal dystrophies in Portugal: the IRD-PT. Orphanet J Rare Dis 15:304. https://doi.org/10.1186/s13023-020-01591-6
doi: 10.1186/s13023-020-01591-6
pubmed: 33109251
pmcid: 7590677
Peter V, Kaminska K, Santos C et al (2023) The first genetic landscape of inherited retinal dystrophies in Portuguese patients identifies recurrent homozygous mutations as a frequent cause of pathogenesis. PNAS Nexus. https://doi.org/10.1093/pnasnexus/pgad043
doi: 10.1093/pnasnexus/pgad043
pubmed: 36909829
pmcid: 10003751
Moye AR, Bedoni N, Cunningham JG et al (2019) Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and mice. PLoS Genet 15:e1008315. https://doi.org/10.1371/journal.pgen.1008315
doi: 10.1371/journal.pgen.1008315
pubmed: 31425546
pmcid: 6715254
Peter VG, Quinodoz M, Sadio S et al (2022) New clinical and molecular evidence linking mutations in ARSG to Usher syndrome type IV. Hum Mutat 43:2326–2327. https://doi.org/10.1002/humu.24496
doi: 10.1002/humu.24496
pubmed: 36317447
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet 17:405–424. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30
Marques JP, Pires J, Costa J et al (2021) Inherited retinal degenerations in Portugal: addressing the unmet needs. Acta Med Port 34:332–334. https://doi.org/10.20344/amp.15802
doi: 10.20344/amp.15802
pubmed: 33834989
Marques JP, Porto FBO, Carvalho AL et al (2022) EYS-associated sector retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 260:1405–1413. https://doi.org/10.1007/s00417-021-05411-w
doi: 10.1007/s00417-021-05411-w
Marques JP, Marta A, Geada S et al (2022) Clinical/demographic functional testing and multimodal imaging differences between genetically solved and unsolved retinitis pigmentosa. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd 245:134–143. https://doi.org/10.1159/000520305
doi: 10.1159/000520305
Marques JP, Neves E, Geada S et al (2022) Frequency of cystoid macular edema and vitreomacular interface disorders in genetically solved syndromic and non-syndromic retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 260:2859–2866. https://doi.org/10.1007/s00417-022-05649-y
doi: 10.1007/s00417-022-05649-y
Marques JP, Pinheiro R, Carvalho AL et al (2022) Genetic spectrum, retinal phenotype, and peripapillary RNFL thickness in RPGR heterozygotes. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. https://doi.org/10.1007/s00417-022-05809-0
doi: 10.1007/s00417-022-05809-0
Soares RM, Carvalho AL, Simão S et al (2023) EYS-associated retinal degeneration: natural history, genetic landscape and phenotypic spectrum. Ophthalmol Retina S2468–6530(23):00054–00064. https://doi.org/10.1016/j.oret.2023.02.001
doi: 10.1016/j.oret.2023.02.001
Geada S, Santos C, Vaz-Pereira S et al (2022) Molecular and multimodal retinal imaging findings in a multicentric Portuguese cohort of Stargardt disease. Rev Soc Port Oftalmol 46:15–24. https://doi.org/10.48560/rspo.25968
doi: 10.48560/rspo.25968
Cortinhal T, Geada S, Neves E et al (2022) Genomic landscape and natural history of sector retinitis pigmentosa. Rev Soc Port Oftalmol 46:25–32. https://doi.org/10.48560/rspo.25958
doi: 10.48560/rspo.25958
Stone EM, Andorf JL, Whitmore SS et al (2017) Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology 124:1314–1331. https://doi.org/10.1016/j.ophtha.2017.04.008
doi: 10.1016/j.ophtha.2017.04.008
pubmed: 28559085
Bycroft C, Fernandez-Rozadilla C, Ruiz-Ponte C et al (2019) Patterns of genetic differentiation and the footprints of historical migrations in the Iberian Peninsula. Nat Commun 10:551. https://doi.org/10.1038/s41467-018-08272-w
doi: 10.1038/s41467-018-08272-w
pubmed: 30710075
pmcid: 6358624
Fuster-García C, García-Bohórquez B, Rodríguez-Muñoz A et al (2021) Usher syndrome: genetics of a human ciliopathy. Int J Mol Sci 22:6723. https://doi.org/10.3390/ijms22136723
doi: 10.3390/ijms22136723
pubmed: 34201633
pmcid: 8268283
Millán JM, Aller E, Jaijo T et al (2011) An update on the genetics of Usher syndrome. J Ophthalmol 2011:417217. https://doi.org/10.1155/2011/417217
doi: 10.1155/2011/417217
pubmed: 21234346
Jouret G, Poirsier C, Spodenkiewicz M et al (2019) Genetics of usher syndrome: new insights from a meta-analysis. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 40:121–129. https://doi.org/10.1097/MAO.0000000000002054
doi: 10.1097/MAO.0000000000002054
Cox KF, Kerr NC, Kedrov M et al (2012) Phenotypic expression of Bardet-Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene. Vision Res 75:77–87. https://doi.org/10.1016/j.visres.2012.08.005
doi: 10.1016/j.visres.2012.08.005
pubmed: 22940089
Niederlova V, Modrak M, Tsyklauri O et al (2019) Meta-analysis of genotype-phenotype associations in Bardet-Biedl syndrome uncovers differences among causative genes. Hum Mutat 40:2068–2087. https://doi.org/10.1002/humu.23862
doi: 10.1002/humu.23862
pubmed: 31283077
Pennings RJE, Te Brinke H, Weston MD et al (2004) USH2A mutation analysis in 70 Dutch families with Usher syndrome type II. Hum Mutat 24:185. https://doi.org/10.1002/humu.9259
doi: 10.1002/humu.9259
pubmed: 15241801
Dad S, Rendtorff ND, Tranebjærg L et al (2016) Usher syndrome in Denmark: mutation spectrum and some clinical observations. Mol Genet Genomic Med 4:527–539. https://doi.org/10.1002/mgg3.228
doi: 10.1002/mgg3.228
pmcid: 5023938
Leroy BP, Aragon-Martin JA, Weston MD et al (2001) Spectrum of mutations in USH2A in British patients with Usher syndrome type II. Exp Eye Res 72:503–509. https://doi.org/10.1006/exer.2000.0978
doi: 10.1006/exer.2000.0978
pubmed: 11311042
Bonnet C, Grati M, Marlin S et al (2011) Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. Orphanet J Rare Dis 6:21. https://doi.org/10.1186/1750-1172-6-21
doi: 10.1186/1750-1172-6-21
pubmed: 21569298
pmcid: 3125325
Colombo L, Maltese PE, Castori M et al (2021) Molecular epidemiology in 591 Italian probands with nonsyndromic retinitis pigmentosa and usher syndrome. Invest Ophthalmol Vis Sci 62:13. https://doi.org/10.1167/iovs.62.2.13
doi: 10.1167/iovs.62.2.13
pubmed: 33576794
pmcid: 7884295
Iftikhar M, Usmani B, Sanyal A et al (2019) Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study. Clin Experiment Ophthalmol 47:605–613. https://doi.org/10.1111/ceo.13458
doi: 10.1111/ceo.13458
pubmed: 30552737
Fragiotta S, Rossi T, Carnevale C et al (2019) Vitreo-macular interface disorders in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 257:2137–2146. https://doi.org/10.1007/s00417-019-04418-8
doi: 10.1007/s00417-019-04418-8
Liew G, Strong S, Bradley P et al (2019) Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa. Br J Ophthalmol 103:1163–1166. https://doi.org/10.1136/bjophthalmol-2018-311964
doi: 10.1136/bjophthalmol-2018-311964
pubmed: 30291136